These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18477489)

  • 21. Injectable contraception: the USA perspective.
    Kaunitz AM
    IPPF Med Bull; 1992 Dec; 26(6):1-3. PubMed ID: 12346920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adolescent use of the monthly contraceptive injection.
    Tuchman LK; Huppert JS; Huang B; Slap GB
    J Pediatr Adolesc Gynecol; 2005 Aug; 18(4):255-60. PubMed ID: 16171729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The future for injectable contraceptives.
    Rutter T
    Afr Health; 1993 Mar; 15(3):18-9. PubMed ID: 12344840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnancy and the risk of HIV-1 acquisition among women in Uganda and Zimbabwe.
    Morrison CS; Wang J; Van Der Pol B; Padian N; Salata RA; Richardson BA
    AIDS; 2007 May; 21(8):1027-34. PubMed ID: 17457097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective cohort study of the feasibility and acceptability of depot medroxyprogesterone acetate administered subcutaneously through self-injection.
    Cover J; Namagembe A; Tumusiime J; Lim J; Drake JK; Mbonye AK
    Contraception; 2017 Mar; 95(3):306-311. PubMed ID: 27789309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Observational study of the acceptability of Sayana® Press among intramuscular DMPA users in Uganda and Senegal.
    Burke HM; Mueller MP; Perry B; Packer C; Bufumbo L; Mbengue D; Mall I; Daff BM; Mbonye AK
    Contraception; 2014 May; 89(5):361-7. PubMed ID: 24631328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Return of ovulation after the cessation of depot-medroxy progesterone acetate treatment in Thai women.
    Saxena BN; Dusitsin N; Tankeyoon M; Chaudhury RR
    J Med Assoc Thai; 1980 Feb; 63(2):66-9. PubMed ID: 7365344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormonal contraceptive use and discontinuation among HIV-infected women in Uganda and Zimbabwe.
    Bengtson A; Kwok C; Salata RA; Byamugisha J; Chipato T; Rwambuya S; Moyo P; Morrison CS
    J Acquir Immune Defic Syndr; 2013 Aug; 63(4):506-13. PubMed ID: 23572011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discontinuation of oral contraceptives and depot medroxyprogesterone acetate among women with and without HIV in Uganda, Zimbabwe and Thailand.
    Nanda K; Morrison CS; Kwok C; Byamugisha J; Jones L; Sriplienchan S; Magwali T
    Contraception; 2011 Jun; 83(6):542-8. PubMed ID: 21570552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [20 questions aporopos of trimestrial injection of depot contraceptives].
    Revaz C
    Rev Med Suisse Romande; 1975 Sep; 95(9):661-71. PubMed ID: 1215719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timeliness of contraceptive reinjections in South Africa and its relation to unintentional discontinuation.
    Baumgartner JN; Morroni C; Mlobeli RD; Otterness C; Myer L; Janowitz B; Stanback J; Buga G
    Int Fam Plan Perspect; 2007 Jun; 33(2):66-74. PubMed ID: 17588850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of two strategies for the administration of injectable depot medroxyprogesterone acetate: among women who returned to a family planning clinic at three- or six-month intervals.
    Ferreira JM; Bottura BF; Gonçalves MP; Monteiro I; Bahamondes L
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):408-11. PubMed ID: 27530899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Same-day administration of depot-medroxyprogesterone acetate injection: a retrospective chart review.
    Balkus J; Miller L
    Contraception; 2005 May; 71(5):395-8. PubMed ID: 15854642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary tract infection in the users of depot-medroxyprogesterone acetate.
    Ziaei S; Ninavaei M; Faghihzadeh S
    Acta Obstet Gynecol Scand; 2004 Oct; 83(10):909-11. PubMed ID: 15453884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term use of hormonal contraceptive DMPA not linked to breast cancer.
    Prog Hum Reprod Res; 1995; (33):5. PubMed ID: 12289977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanding contraceptive choices: lunelle monthly contraceptive injection.
    Shulman LP
    Int J Fertil Womens Med; 2000; 45(2):190-4. PubMed ID: 10831189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Provider acceptability of Sayana® Press: results from community health workers and clinic-based providers in Uganda and Senegal.
    Burke HM; Mueller MP; Packer C; Perry B; Bufumbo L; Mbengue D; Daff BM; Mbonye A
    Contraception; 2014 May; 89(5):368-73. PubMed ID: 24576792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Merits of DMPA relative to other reversible contraceptive methods.
    Nelson A
    J Reprod Med; 2002 Sep; 47(9 Suppl):781-4. PubMed ID: 12380406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Millions of couples to have choice of injectable contraceptive.
    Integration; 1996; (47):41. PubMed ID: 12347310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic side-effects of injectable depot-medroxyprogesterone acetate, 150 mg three-monthly, in undernourished lactating women. WHO Task Force on Long-acting Agents for Fertility Regulation.
    WHO Task Force on Long-acting Agents for Fertility Regulation
    Bull World Health Organ; 1986; 64(4):587-94. PubMed ID: 3490928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.